Orphan Reach are in business to provide the biopharmaceutical industry with the ultimate product lifecycle solution including clinical support and integrated patient management. We pioneer multi-stakeholder partnerships in the rare disease domain. We believe in a collaborative approach and the fact that we need to unite the best in class providers for the ultimate benefit of patients desperately waiting for new treatments.
The purpose of Orphan Reach is to expedite the development of orphan drugs and facilitate patient access to treatments which can improve the quality of life of patients and their families. By driving best practice our team can provide continued, seamless, high quality support to biopharmaceutical companies throughout any stage of the orphan product lifecycle.